Search Results - I. A. Urvantseva
- Showing 1 - 13 results of 13
-
1
-
2
Chronic heart failure: modern problems and their solutions by V. S. Nesterov, I. A. Urvantseva, A. S. Vorobev
Published 2021-06-01
Article -
3
A CLINICAL CASE: A GIANT MYXOMA OF THE LEFT ATRIUM by A. N. Shilenko, I. N. Bachinskaya, V. S. Mataev, I. A. Urvantseva
Published 2014-05-01
Article -
4
-
5
-
6
-
7
-
8
Lipoprotein transport and metabolism markers in patients with myocardial infarction in the Biobank of Yugra blood sample collection by A. S. Vorobyov, M. Yu. Donnikov, O. S. Glotov, L. V. Kovalenko, K. Yu. Nikolaev, I. A. Urvantseva, Yu. A. Drenina, A. V. Morozkina, G. N. Chernysheva
Published 2025-01-01
Article -
9
Clinically significant CYP2C19 genotypes in patients with myocardial infarction in the northern region of Russia by A. S. Vorobyov, G. I. Lifshits, E. M. Zelenskaya, K. Yu. Batueva, L. V. Kovalenko, I. A. Urvantseva, M. Yu. Donnikov, A. V. Morozkina, K. Yu. Nikolaev
Published 2023-11-01
Article -
10
Regional aspects of associations of the CYP2C19 gene polymorphism with coronary atherosclerosis in acute coronary syndrome by K. Yu. Nikolaev, I. A. Urvantseva, K. Yu. Batueva, K. A. Apartsin, A. V. Gorokhova, V. I. Ganyukov, N. A. Kochergin, E. M. Zelenskaya, G. I. Lifshitz
Published 2018-11-01
Article -
11
REGIONAL ASPECTS OF THE GENE POLYMORPHISM VЕGFR2 WITH CORONARY ATHEROSCLEROSIS IN ACUTE CORONARY SYNDROME by K. Yu. Nikolaev, I. A. Urvantseva, К. Yu. Batueva, К. A. Apartsin, А. V. Gorokhova, V. I. Ganyukov, N. А. Kochergin, Е. M. Zelenskaya, G. I. Lifshits
Published 2017-11-01
Article -
12
Efficacy of P2Y<sub>12</sub> receptor inhibitors in myocardial infarction in individuals carrying different <i>CYP2C19</i> genotypes living in the northern region of Russia by A. S. Vorobyov, G. I. Lifshits, E. M. Zelenskaya, K. Yu. Batueva, L. V. Kovalenko, I. A. Urvantseva, M. Yu. Donnikov, M. S. Poptsova, E. P. Zbirovskaya, K. Yu. Nikolaev
Published 2024-11-01
Article -
13
Register of patients with familial hypercholesterolemia and patients of very high cardiovascular risk with lipid-lowering therapy underperformance (RENESSANS) by M. V. Yezhov, S. A. Bliznyuk, N. A. Tmoyan, T. A. Rozhkova, D. V. Duplyakov, V. A. Salchenko, M. A. Kachkovsky, I. I. Shaposhnik, V. V. Genkel, V. S. Gurevich, S. А. Urazgildeeva, A. V. Tregubov, M. V. Muzalevskaya, S. S. Bazhan, O. V. Timoshchenko, I. A. Urvantseva, K. G. Kozhokar, A. A. Sokolov, V. V. Tishko, O. I. Boyeva, E. V. Bolotova, A. M. Namitokov, Yu. B. Kushnaryova, T. Yu. Kuznetsova, V. A. Korneva, D. Yu. Bogdanov, E. E. Chichina, V. M. Solovyov, A. I. Ershova, A. N. Meshkov, V. I. Makogonenko, A. S. Galyavich, D. I. Sadykova, B. V. Pomogaybo, O. L. Barbarash, V. V. Kashtalap, E. A. Shutemova, I. G. Isaeva, R. A. Khokhlov, V. E. Oleynikov, I. V. Avdeeva, V. V. Malakhov, U. V. Chubykina, V. O. Konstantinov, A. S. Aliyeva, V. V. Ovsyannikova, G. I. Furmenko, T. M. Chernykh, O. E. Abashina, A. R. Dzhanibekova, E. S. Slastnikova, L. F. Galimova, P. D. Duplyakova, M. I. Voyevoda
Published 2019-06-01
Article